This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Tirzepatide: a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) dual agonist in development for the treatment of type 2 diabetes.
Expert review of endocrinology & metabolism, 15(6), 379-394
Citation
Frías, Juan P. (2020). Tirzepatide: a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) dual agonist in development for the treatment of type 2 diabetes.. Expert review of endocrinology & metabolism, 15(6), 379-394. https://doi.org/10.1080/17446651.2020.1830759